163 related articles for article (PubMed ID: 31881259)
1. RAMP1 and RAMP3 Differentially Control Amylin's Effects on Food Intake, Glucose and Energy Balance in Male and Female Mice.
Coester B; Pence SW; Arrigoni S; Boyle CN; Le Foll C; Lutz TA
Neuroscience; 2020 Nov; 447():74-93. PubMed ID: 31881259
[TBL] [Abstract][Full Text] [Related]
2. A selective role for receptor activity-modifying proteins in subchronic action of the amylin selective receptor agonist NN1213 compared with salmon calcitonin on body weight and food intake in male mice.
Arrigoni S; Le Foll C; Cabak A; Lundh S; Raun K; John LM; Lutz TA
Eur J Neurosci; 2021 Aug; 54(3):4863-4876. PubMed ID: 34189795
[TBL] [Abstract][Full Text] [Related]
3. The calcitonin receptor is the main mediator of LAAMA's body weight lowering effects in male mice.
Gamakharia S; Le Foll C; Rist W; Baader-Pagler T; Baljuls A; Lutz TA
Eur J Pharmacol; 2021 Oct; 908():174352. PubMed ID: 34274340
[TBL] [Abstract][Full Text] [Related]
4. Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat.
Oliver KR; Kane SA; Salvatore CA; Mallee JJ; Kinsey AM; Koblan KS; Keyvan-Fouladi N; Heavens RP; Wainwright A; Jacobson M; Dickerson IM; Hill RG
Eur J Neurosci; 2001 Aug; 14(4):618-28. PubMed ID: 11556887
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice.
Pawlak JB; Wetzel-Strong SE; Dunn MK; Caron KM
Peptides; 2017 Feb; 88():1-7. PubMed ID: 27940069
[TBL] [Abstract][Full Text] [Related]
6. Calcitonin and Amylin Receptor Peptide Interaction Mechanisms: INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS.
Lee SM; Hay DL; Pioszak AA
J Biol Chem; 2016 Apr; 291(16):8686-700. PubMed ID: 26895962
[TBL] [Abstract][Full Text] [Related]
7. Amylin receptor components and the leptin receptor are co-expressed in single rat area postrema neurons.
Liberini CG; Boyle CN; Cifani C; Venniro M; Hope BT; Lutz TA
Eur J Neurosci; 2016 Mar; 43(5):653-61. PubMed ID: 26750109
[TBL] [Abstract][Full Text] [Related]
8. Specificity of porcine calcitonin receptor and calcitonin receptor-like receptor in the presence of receptor-activity-modifying proteins.
Kikumoto K; Katafuchi T; Minamino N
Hypertens Res; 2003 Feb; 26 Suppl():S15-23. PubMed ID: 12630807
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of receptor-activity-modifying proteins (RAMPs) and the human calcitonin receptor.
Armour SL; Foord S; Kenakin T; Chen WJ
J Pharmacol Toxicol Methods; 1999 Dec; 42(4):217-24. PubMed ID: 11033437
[TBL] [Abstract][Full Text] [Related]
10. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
[TBL] [Abstract][Full Text] [Related]
11. Peripheral amylin activates circumventricular organs expressing calcitonin receptor a/b subtypes and receptor-activity modifying proteins in the rat.
Barth SW; Riediger T; Lutz TA; Rechkemmer G
Brain Res; 2004 Jan; 997(1):97-102. PubMed ID: 14715154
[TBL] [Abstract][Full Text] [Related]
12. The effects of C-terminal truncation of receptor activity modifying proteins on the induction of amylin receptor phenotype from human CTb receptors.
Udawela M; Christopoulos G; Morfis M; Tilakaratne N; Christopoulos A; Sexton PM
Regul Pept; 2008 Jan; 145(1-3):65-71. PubMed ID: 17884192
[TBL] [Abstract][Full Text] [Related]
13. Amylin and GLP-1 target different populations of area postrema neurons that are both modulated by nutrient stimuli.
Züger D; Forster K; Lutz TA; Riediger T
Physiol Behav; 2013 Mar; 112-113():61-9. PubMed ID: 23438370
[TBL] [Abstract][Full Text] [Related]
14. Viral depletion of calcitonin receptors in the area postrema: A proof-of-concept study.
Coester B; Foll CL; Lutz TA
Physiol Behav; 2020 Sep; 223():112992. PubMed ID: 32497530
[TBL] [Abstract][Full Text] [Related]
15. Receptor activity-modifying proteins differentially modulate the G protein-coupling efficiency of amylin receptors.
Morfis M; Tilakaratne N; Furness SG; Christopoulos G; Werry TD; Christopoulos A; Sexton PM
Endocrinology; 2008 Nov; 149(11):5423-31. PubMed ID: 18599553
[TBL] [Abstract][Full Text] [Related]
16. Amylin brain circuitry.
Boccia L; Gamakharia S; Coester B; Whiting L; Lutz TA; Le Foll C
Peptides; 2020 Oct; 132():170366. PubMed ID: 32634450
[TBL] [Abstract][Full Text] [Related]
17. Functional relevance of G-protein-coupled-receptor-associated proteins, exemplified by receptor-activity-modifying proteins (RAMPs).
Fischer JA; Muff R; Born W
Biochem Soc Trans; 2002 Aug; 30(4):455-60. PubMed ID: 12196114
[TBL] [Abstract][Full Text] [Related]
18. Structure-function analysis of RAMP1-RAMP3 chimeras.
Qi T; Simms J; Bailey RJ; Wheatley M; Rathbone DL; Hay DL; Poyner DR
Biochemistry; 2010 Jan; 49(3):522-31. PubMed ID: 20017504
[TBL] [Abstract][Full Text] [Related]
19. Structure-function analysis of amino acid 74 of human RAMP1 and RAMP3 and its role in peptide interactions with adrenomedullin and calcitonin gene-related peptide receptors.
Qi T; Ly K; Poyner DR; Christopoulos G; Sexton PM; Hay DL
Peptides; 2011 May; 32(5):1060-7. PubMed ID: 21402116
[TBL] [Abstract][Full Text] [Related]
20. Changes in the expression of calcitonin receptor-like receptor, receptor activity-modifying protein (RAMP) 1, RAMP2, and RAMP3 in rat uterus during pregnancy, labor, and by steroid hormone treatments.
Thota C; Gangula PR; Dong YL; Yallampalli C
Biol Reprod; 2003 Oct; 69(4):1432-7. PubMed ID: 12801991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
